Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yushi Bai

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2017
Protamine is an antagonist of apelin receptor, and its activity is reversed by heparinSophie Le Gonidec, Carline Chaves-Almagro, Yushi Bai, et al.
Biochemistry|May 4, 2011
Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Karla E Madrigal, Dow P Hurst, et al.
Journal of Medicinal Chemistry|August 8, 2019
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric ModulatorsAnthony B Pinkerton, Satyamaheshwar Peddibhotla, Fusayo Yamamoto, et al.
Molecular Pharmacology|September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityPingwei Zhao, Haleli Sharir, Ankur Kapur, et al.
ACS Chemical Biology|April 28, 2016
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine AbuseLarry S Barak, Yushi Bai, Sean Peterson, et al.
Biochemistry|November 27, 2013
Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Haleli Sharir, Derek M Shore, et al.
Cell|May 30, 2020
β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsLauren M Slosky, Yushi Bai, Krisztian Toth, et al.
Nature Communications|November 20, 2020
PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophreniaTanner O Monroe, Melanie E Garrett, Maria Kousi, et al.
Cancers|February 13, 2025
Core Patient-Centered Outcomes for Adolescents and Young Adults with Cancer: A Comprehensive Review of the Literature from the STRONG-AYA ProjectSilvie H M Janssen, Winette T A van der Graaf, Anna Hurley-Wallace, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2017
Protamine is an antagonist of apelin receptor, and its activity is reversed by heparinSophie Le Gonidec, Carline Chaves-Almagro, Yushi Bai, et al.
Biochemistry|May 4, 2011
Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Karla E Madrigal, Dow P Hurst, et al.
Journal of Medicinal Chemistry|August 8, 2019
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric ModulatorsAnthony B Pinkerton, Satyamaheshwar Peddibhotla, Fusayo Yamamoto, et al.
Molecular Pharmacology|September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityPingwei Zhao, Haleli Sharir, Ankur Kapur, et al.
ACS Chemical Biology|April 28, 2016
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine AbuseLarry S Barak, Yushi Bai, Sean Peterson, et al.
Biochemistry|November 27, 2013
Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Haleli Sharir, Derek M Shore, et al.
Cell|May 30, 2020
β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsLauren M Slosky, Yushi Bai, Krisztian Toth, et al.
Nature Communications|November 20, 2020
PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophreniaTanner O Monroe, Melanie E Garrett, Maria Kousi, et al.
Cancers|February 13, 2025
Core Patient-Centered Outcomes for Adolescents and Young Adults with Cancer: A Comprehensive Review of the Literature from the STRONG-AYA ProjectSilvie H M Janssen, Winette T A van der Graaf, Anna Hurley-Wallace, et al.
Pageof 5